INTERLEUKIN-10 INHIBITS T-CELL ALLOREACTION INDUCED BY HUMAN DENDRITIC CELLS

被引:176
|
作者
CAUX, C
MASSACRIER, C
VANBERVLIET, B
BARTHELEMY, C
LIU, YJ
BANCHEREAU, J
机构
[1] Laboratory for immundogical Research, 69571 Dardilty, 27 chemin des Peupliers
关键词
CD1A(+) CELLS; CD4(+) T CELLS; CD8(+) T CELLS; CYTOKINE PRODUCTION; GM-CSF; HEMATOPOIETIC PROGENITORS; LANGERHANS CELLS; TNF-ALPHA;
D O I
10.1093/intimm/6.8.1177
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human dendritic cells (DC) generated from CD34(+) hematopoietic progenitors cultured in the presence of granulocyte macrophage colony stimulating factor (GM-CSF) and tumor necrosis factor (TNF)-alpha are related to Langerhans cells (DLC) and have been shown to induce a strong proliferation of allogeneic CD4(+) T cells. The present study shows that recombinant human IL-10 (h-IL-10) inhibits the primary and secondary proliferative responses of both CD4(+) and CD8(+) T cells induced by allogeneic CD1a(+) DLC. The alloreaction induced by DLC generated after 5-18 days of culture of CD34(+) HPC was equally inhibited by h-IL-10, thus indicating that DLC were sensitive to h-IL-10 at all stages of differentiation. This is further indicated by the h-IL-10-induced inhibition of the T cell alloreaction mediated by interdigitating DC freshly isolated from tonsils. h-IL-10 specifically acted on DLC as it did not affect the proliferation induced by Epstein - Barr virus lymphoblastoid cell lines (EBV-LCL) nor that induced by immobilized anti-CD3. The inhibitory effect of h-IL-10 was not due to the production of suppressive factors by the DLC, as the addition of DLC and IL-10 did not inhibit EBV-LCL-induced T cell proliferation. Rather, the inhibition of cytokine production (IL-2, GM-CSF, TNF, IFN-gamma) observed after 24 h of co-culture may explain the inhibition of T cell DNA synthesis detected 3 days later. The h-IL-10-induced inhibition of human DC mediated alloreaction advocates considering the use of h-IL-10 in the prevention of transplant rejection and graft versus host disease, phenomena initiated by DC.
引用
收藏
页码:1177 / 1185
页数:9
相关论文
共 50 条
  • [1] INTERLEUKIN-10 INHIBITS THE PRIMARY ALLOGENEIC T-CELL RESPONSE TO HUMAN EPIDERMAL LANGERHANS CELLS
    PEGUETNAVARRO, J
    MOULON, C
    CAUX, C
    DALBIEZGAUTHIER, C
    BANCHEREAU, J
    SCHMITT, D
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (04) : 884 - 891
  • [2] INTERLEUKIN-10 INHIBITS HUMAN T-CELL PROLIFERATION AND IL-2 PRODUCTION
    TAGA, K
    TOSATO, G
    [J]. FASEB JOURNAL, 1992, 6 (04): : A1333 - A1333
  • [3] The role of interleukin-10 in T-cell tolerance
    Roncarolo, MG
    LundJohansen, F
    Groux, H
    deVries, JE
    [J]. IMMUNE TOLERANCE: INTERNATIONAL SYMPOSIUM ON IMMUNE TOLERANCE, 1996, : 141 - 147
  • [4] HUMAN INTERLEUKIN-10 CAN DIRECTLY INHIBIT T-CELL GROWTH
    TAGA, K
    MOSTOWSKI, H
    TOSATO, G
    [J]. BLOOD, 1993, 81 (11) : 2964 - 2971
  • [5] Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness.
    Takayama, T
    Nishioka, Y
    Lu, L
    Lotze, MT
    Tahara, H
    Thomson, AW
    [J]. TRANSPLANTATION, 1998, 66 (12) : 1567 - 1574
  • [6] INTERLEUKIN-10 IS A CYTOTOXIC T-CELL DIFFERENTIATION FACTOR
    ZLOTNIK, A
    CHEN, WF
    [J]. FASEB JOURNAL, 1991, 5 (05): : A974 - A974
  • [7] INTERLEUKIN-10 IS A HUMAN T-CELL GROWTH-FACTOR IN-VITRO
    PAWELEC, G
    POHLA, H
    SCHOLTZ, E
    REHBEIN, A
    SCHAUDT, K
    HAMBRECHT, A
    FRICCIUS, H
    [J]. CYTOKINE, 1995, 7 (04) : 355 - 363
  • [8] Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality
    Chang, WLW
    Baumgarth, N
    Yu, D
    Barry, PA
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (16) : 8720 - 8731
  • [9] Interleukin-10 gene expression in adult T-cell leukemia
    Mori, N
    Gill, PS
    Mougdil, T
    Murakami, S
    Eto, S
    Prager, D
    [J]. BLOOD, 1996, 88 (03) : 1035 - 1045
  • [10] Interleukin-10 gene expression and adult T-cell leukemia
    Mori, N
    Prager, D
    [J]. LEUKEMIA & LYMPHOMA, 1998, 29 (3-4) : 239 - 248